Auryxia (Ferric Citrate) Therapy for In-Center and Home Dialysis Participants
Public ClinicalTrials.gov record NCT04922645. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Impact of Auryxia (Ferric Citrate) on Erythropoiesis-Stimulating Agent (ESA) Use, Intravenous (IV) Iron Use, Phosphate Control, and Anemia Control in Adult Participants on In-Center Hemodialysis or Home Dialysis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is being conducted to demonstrate the effect of Auryxia, when used as the primary phosphate lowering therapy, on the overall cumulative use of erythropoiesis-stimulating agent and intravenous iron as well as on the laboratory parameters indicative of phosphate and anemia management.
Study identification
- NCT ID
- NCT04922645
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 214 participants
Conditions and interventions
Interventions
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 29, 2021 (Actual)
- Primary completion
- Sep 15, 2022 (Actual)
- Completion
- Sep 15, 2022 (Actual)
- Last update posted
- Nov 7, 2022
2021 – 2022
United States locations
- U.S. sites
- 13
- U.S. states
- 8
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| US Renal Care - Dimond | Anchorage | Alaska | 99515 | — |
| US Renal Care - Mesa | Mesa | Arizona | 85210 | — |
| US Renal Care - Pine Bluff | Pine Bluff | Arkansas | 71603 | — |
| US Renal Care - Northridge Roscoe | Granada Hills | California | 91325 | — |
| US Renal Care - Dalton | Dalton | Georgia | 30720 | — |
| US Renal Care - Major Health | Shelbyville | Indiana | 46176 | — |
| US Renal Care - Red Rocks | Gallup | New Mexico | 87301 | — |
| US Renal Care - North Dallas | Dallas | Texas | 75231 | — |
| Dallas Renal Group | Dallas | Texas | 75237 | — |
| US Renal Care - Houston Street | San Antonio | Texas | 78202 | — |
| US Renal Care - Palo Alto | San Antonio | Texas | 78221 | — |
| US Renal Care - Pleasanton Rd. | San Antonio | Texas | 78221 | — |
| US Renal Care - Westover Hills | San Antonio | Texas | 78251 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04922645, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 7, 2022 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04922645 live on ClinicalTrials.gov.